Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2006
Effects of long-term low-dose corticosteroid therapy on humoral immunity.
Клинический случайСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fedor Mary E, Rubinstein Arye
Аннотация
BACKGROUND: Corticosteroids are agents that suppress the immune system. Their suppressive activity is predominantly restricted to cell-mediated immunity, with a marginal inhibitory effect on humoral immunity.
OBJECTIVE: To describe an acquired reversible B-cell deficiency in a patient treated with low-dose corticosteroids for 36 years.
METHODS: A broad range of T- and B-cell parameters were studied over time, during and after discontinuation of corticosteroid therapy. Published works on this topic in animal and human models are reviewed. The findings unique to this patient are highlighted.
RESULTS: While undergoing long-term corticosteroid therapy, a patient developed a clinical and immunologic picture suggestive of common variable immunodeficiency, with predominantly qualitative and quantitative B-cell abnormalities. These abnormalities resolved within 2 years after tapering of corticosteroid therapy.
CONCLUSIONS: Long-term low-dose corticosteroid use may reversibly decrease B-cell counts and specific antibody responses.
OBJECTIVE: To describe an acquired reversible B-cell deficiency in a patient treated with low-dose corticosteroids for 36 years.
METHODS: A broad range of T- and B-cell parameters were studied over time, during and after discontinuation of corticosteroid therapy. Published works on this topic in animal and human models are reviewed. The findings unique to this patient are highlighted.
RESULTS: While undergoing long-term corticosteroid therapy, a patient developed a clinical and immunologic picture suggestive of common variable immunodeficiency, with predominantly qualitative and quantitative B-cell abnormalities. These abnormalities resolved within 2 years after tapering of corticosteroid therapy.
CONCLUSIONS: Long-term low-dose corticosteroid use may reversibly decrease B-cell counts and specific antibody responses.
Предметные рубрики MeSH
AcetatesAgammaglobulinemiaAlbuterolAnti-Asthmatic AgentsAntibodies, BacterialAntibody FormationAsthmaB-LymphocytesCyclopropanesDrug Therapy, CombinationFemaleHumansImmunoglobulin GImmunologic MemoryLymphopeniaMethylprednisoloneMiddle AgedNasal PolypsPneumococcal VaccinesQuinolinesSinusitisSulfidesT-Lymphocyte Subsets